Beyond that: Consider Tirzepatide If: You want an FDA-approved, commercially available medication You have type 2 diabetes (Mounjaro is specifically approved for this) You prefer a medication with more long-term safety data Your insurance covers tirzepatide You need predictable access to medication supply Consider Waiting for Retatrutide If: You've plateaued on other GLP-1 medications You're interested in the potential metabolic benefits of glucagon activation You're comfortable waiting for FDA approval (expected 2027) You want potentially greater fat loss based on early trial data Switching From Tirzepatide to Retatrutide No established dose conversion exists
Although some xenobiotics such as phenobarbital are associated with hepatocellular hypertrophy throughout a long-term administration, the initial hypertrophy associated with other xenobiotics such as safrole and Ponceau is not sustained (Crampton et al
The most important thing is to stay consistent once youve made the change, and to make sure youre not taking doses too close together during the transition
If you're considering Ozempic for diabetes or weight loss, having a baseline comprehensive eye exam beforehand is wise
Compounding a drug not in shortage would need to meet one of the FDAs exceptions
Guests with new, severe, persistent, or unexplained symptoms